KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edgewell Personal Care (EPC) Shares Outstanding (Diluted Average) (2023 - 2026)

Edgewell Personal Care has reported Shares Outstanding (Diluted Average) over the past 3 years, most recently at $46.6 million for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) fell 4.31% to $46.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.6 million through Dec 2025, down 4.31% year-over-year, with the annual reading at $47.6 million for FY2025, 4.99% down from the prior year.
  • Shares Outstanding (Diluted Average) was $46.6 million for Q4 2025 at Edgewell Personal Care, down from $47.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $51.8 million in Q3 2023 and troughed at $46.6 million in Q4 2025.
  • The 3-year median for Shares Outstanding (Diluted Average) is $49.4 million (2024), against an average of $49.2 million.
  • Year-over-year, Shares Outstanding (Diluted Average) dropped 3.28% in 2024 and then dropped 4.99% in 2025.
  • A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $50.5 million in 2023, then decreased by 3.56% to $48.7 million in 2024, then decreased by 4.31% to $46.6 million in 2025.
  • Per Business Quant, the three most recent readings for EPC's Shares Outstanding (Diluted Average) are $46.6 million (Q4 2025), $47.6 million (Q3 2025), and $48.0 million (Q2 2025).